Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Regulating Heart and Kidney Formula (Tiao Xin Bu Shen Fang) is a Traditional Chinese Medicine (TCM) herbal combination developed by the Shanghai Geriatric Institute of Chinese Medicine for the treatment of Alzheimer's disease. The formula is grounded in the classical TCM theories of 'The Heart Governs the Mind' and 'The Kidney Stores Essence,' which posit that cognitive decline is fundamentally linked to physiological disharmony between the heart and kidney systems. It is primarily indicated for patients with early-stage Alzheimer's disease, aiming to improve cognitive function and slow disease progression. The formula is currently being evaluated in clinical trials (e.g., ChiCTR2400082701) to investigate its clinical efficacy and safety profile in managing cognitive impairment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Regulating Heart and Kidney Formula (Shanghai Geriatric Institute of Chinese Medicine).